EQS-News: New Formula Leverages Proenkephalin A 119-159 (pen

Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients 05.10.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. P...

Related Keywords

Netherlands , Berlin , Germany , Hennigsdorf , Brandenburg , United States , Sphingotec Gmbh , Ruxandra Lenz , Florian Uhle , Sphingotec Gmb , Pickkerset Al , Research Update Study , Radboud University , Disease Quality Initiative , Adm , Distribution Services , Peter Pickkers Head Of Research , Radboud University Medical Centre , Kidney International , Formula Leverages Proenkephalin , Critically Ill Patients , Mayo Clinic , Peter Pickkers , Intensive Care Medicine , Radboud University Nijmegen Medical Centre , Medical Director , Kidney International Reports , Acute Disease Quality Initiative , Nature Reviews Nephrology , Intensive Care Med Exp , Tec Gmbh , Corporate News , Regulatory Announcements , Update Study , Few , Formula , Beverages , Roenkephalin , , Mproved , Fr , Estimation , Steady State , Critically , Wall , Patients , Et Cest , The ,